Volume 19, Issue 4, Pages (April 2017)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 12, Pages (December 2014)
Advertisements

Volume 342, Issue 1, Pages (January 2014)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 355, Issue 2, Pages (December 2014)
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Cell Physiol Biochem 2017;44:1867– DOI: /
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Cell Physiol Biochem 2015;36: DOI: /
Volume 145, Issue 2, Pages (August 2013)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 19, Issue 4, Pages (April 2017)
Volume 133, Issue 2, Pages (August 2007)
MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration  Dongqing Li, X.I. Li, Aoxue Wang, Florian Meisgen, Andor.
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 135, Issue 5, Pages e24 (November 2008)
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
Volume 21, Issue 10, Pages (October 2013)
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
Volume 137, Issue 2, Pages e2 (August 2009)
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
Volume 145, Issue 4, Pages e9 (October 2013)
PTF1α/p48 and cell proliferation
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 19, Issue 2, Pages (February 2017)
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 141, Issue 6, Pages (December 2011)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 136, Issue 2, Pages (February 2009)
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma  Futoshi Ishiguro, MD, Hideki Murakami, MD,
Yuen Yee Cheng, PhD, Michaela B
Volume 19, Issue 3, Pages (March 2017)
Volume 21, Issue 6, Pages (June 2013)
Volume 19, Issue 3, Pages (March 2017)
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Volume 152, Issue 1, Pages (January 2019)
Volume 22, Issue 10, Pages (October 2014)
Molecular Therapy - Nucleic Acids
Volume 19, Issue 4, Pages (April 2017)
Volume 145, Issue 2, Pages (August 2013)
Molecular Therapy - Nucleic Acids
Volume 10, Issue 1, Pages (July 2011)
Volume 25, Issue 9, Pages (September 2017)
Volume 142, Issue 7, Pages e2 (June 2012)
Brian Poligone, Elaine S. Gilmore, Carolina V
Volume 117, Issue 7, Pages (June 2004)
Robert Schickel, Sun-Mi Park, Andrea E. Murmann, Marcus E. Peter 
Volume 21, Issue 10, Pages (October 2013)
TGFβ/SMAD/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis  Man Jiang, Zhongbin Sun, Erle.
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
Volume 10, Issue 3, Pages (September 2006)
Suppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown System  Haoran Xin, Mingxing Lei, Zhihui Zhang, Jie Li, Hao Zhang,
Volume 127, Issue 4, Pages (October 2004)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Molecular Therapy - Nucleic Acids
Volume 24, Issue 10, Pages (October 2016)
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 10, Issue 1, Pages (July 2011)
Volume 23, Issue 4, Pages (April 2015)
Presentation transcript:

Volume 19, Issue 4, Pages 321-332 (April 2017) MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis  Sanjay Yadav, Nishant Singh, Parag P. Shah, David A. Rowbotham, Danial Malik, Ankita Srivastav, Jai Shankar, Wan L. Lam, William W. Lockwood, Levi J. Beverly  Neoplasia  Volume 19, Issue 4, Pages 321-332 (April 2017) DOI: 10.1016/j.neo.2017.02.001 Copyright © 2017 Terms and Conditions

Figure 1 DEP induced UBQLN protects cells by promoting accumulation of DEP in vacuole-like structures of A549 cells. A) Effect of DEP exposure on protein levels of UBQLN1/2 in A549 cells; B) Effect of DEP exposure on expression of UBQLN1/2 mRNAs in A549 cells; C) Effect of DEP exposure on apoptosis of UBQLN1 over-expressing cells using flow cytometric using anti-AnnexinV and PI staining; D) TEM images of DEP exposed A549 cells over-expressing UBQLN1 or empty vector (EV). Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 2 MIR155 is down-regulated by DEP and is predicted to bind and regulate UBQLN1 and UBQLN2 mRNA. A) Ranking of UBQLN1 targeting miRNAs using miRDB web portal according to their functional annotations (higher the score more the probability of binding); B) Targeting site of MIR155 in 3′-UTR of UBQLN1 and UBQLN2; C) Effect of DEP exposure on expression of MIR155 in A549 cells; D) Kaplan–Meier plot of overall survival of lung adenocarcinoma patients (top) and renal cell carcinoma patients (bottom) stratified by high (dashed) and low (solid) MIR155 expression. E) Box and whiskers plots comparing RSEM of UBQLN expression values in samples with high MIR155 expression (90th percentile) to samples with low MIR155 expression (10th percentile). The box extends from the 25th to the 75th percentile, with the median shown, whereas the whiskers range from 10th to 90th percentile. (Mann–Whitney test, one asterisk P<.05, two asterisks P<.01). Cancer types with a negative correlation between MIR155 and UBQLN expression also had MIR155 expression profiles significantly associated with overall patient survival. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 3 Levels of UBQLN1/2 protein and mRNA expression are regulated by MIR155. A) Effect of transfection of MIR155 mimic (MIR155m) and inhibitor (MIR155i) on protein levels of UBQLN1/2 in A549 and H358 cells; B) Real time PCR of UBQLN1/2 in A549 and H358 cells transfected with MIR155m and MIR155i; C) Confocal images of A549 and H358 cells transfected with MIR155 mimic and inhibitor and probed with anti—UBQLN1/2. Green florescence is represents UBQLN1/2, red florescence represents actin. Cells are counterstained with DAPI for nuclear staining. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 4 3′-untranslated regions (UTR) of UBQLN1 and UBQLN2 are regulated by MIR155. Dual luciferase assay in A549 and 293 T cells transfected with luciferase reporter plasmids pEZX-MT01 (empty vector; EV), pEZX-UBQLN1 (contains 3′-UTR of UBQLN1; 3′-UTR) or pEZX-UBQLN2 (contains 3′-UTR of UBQLN2; 3′-UTR) and MIR155 mimic (155 m) or MIR155 inhibitor (155i) or NTC. Relative luciferase activity was calculated by normalizing firefly luciferase activity with Renilla luciferase activity (transfection control). Relative luciferase activities of cells transfected with 3′-UTR plasmid and NTC is considered as 1 (equals to 100%) and other activities are presented in comparison to them. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 5 Expression of MIR155 induces cell invasion and migration. A) Cell migration and invasion assay in cells transfected with MIR155m, or MIR155i or NTC. After 24 hours of transfection, equal number of cells was seeded into Boyden chambers with (invasion) or without (migration) matrigel. The lower chamber contained the media with serum, whereas upper chamber contained media without chamber. After 48 hours, lower side of membrane were fixed and stained. Cells migrated or invaded are counted manually and presented as bar diagram. B) Scratch assay in A549 cells transfected with MIR155m, or MIR155i or NTC. After 24 hours of transfections, scratch was made using a pipette tip and cells were examined for scratch area, just after making scratches and on following two day. Microscopic images of scratches were analyzed using Image J software and changes in area were calculated considering 0 day as 100%. Values in % represent average scratch area remaining. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 6 Expression of MIR155 induced clonogenic capabilities and proliferation of lung carcinoma cells. A) Cells are transfected with MIR155m or MIR155i or NTC or KIff11 (positive control). After 24 hours of transfection, each well of 6-well dish was plated with 1000 cells and grown for 10 day. After 10 days, cells were fixed, stained and destained as described in methodology. Bar diagram represents average number of colonies counted after staining. B) Alamar blue assay in A549 and H358 cells transfected with MIR155m or MIR155i or Kiff11 or NTC. After 24 hours of transfection, 96 well plate were seeded with 1000 cells/well and Alamar blue assay was carried out on 0 day (day of cell seeding), and next 4 consecutive days. Day 0 was used to normalize the counts of next 4 days for any possible difference in cell seeding. Relative activities were then calculated each day against NTC (considered as 1). Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 7 Expression of MIR155 regulates levels of epithelial and mesenchymal markers. A) Immunoblotting of epithelial (E-cadherin and Claudin1) and mesenchymal (Vimentin and Snail) markers in lysates of A549 or H358 cells transfected with MIR155m, or MIR155i or NTC. B) Immunocytochemical detection of vimentin and E-cadherin in A549 and H358 cells transfected with MIR155m, or MIR155i or NTC. (Florescence: green represents Vimentin or E-Cadherin, red represents actin and blue is from nucleus). Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Figure 8 Over-expression UBQLN1 lacking a 3′-UTR inhibits MIR155 mediated phenotypes. A549 cells are infected with UBQLN1 (U1) or empty vector (EV) and sorted by flow cytometer as described in methodology section. Flow cytometer sorted cells are transfected with MIR155m or NTC and used for different assays: (A) Western blots were performed on Flow sorted cells with anti-FLAG antibody to detect over-expressed exogenous UBQLN1. (B) Western blots were performed after 72 hours following miRNA transfection for EMT markers. (C) Wound healing/scratch assay (D) Colony formation assay, (E) Alamar Blue assay (F) Transfection of MIR155m increased growth and colonization of A549 cells in mice lungs. A549 cells were infected with viruses containing MIG-RX (empty vector; EV) or MIG-UBQLN1 (U1) and sorted with flow cytometer using GFP as marker as described in methods. GFP sorted cells are transfected with NTC or MIR155m. After 24 hours of transfection, five mice in each group are injected with 1×106/mice. After 30 days of injection, mice were scarified and total lung weight was measured and GFP florescence was measured using animal imager. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Supplemental Figure S1 (supporting Figure 1C). Effect of DEP exposure on apoptosis of UBQLN1 over-expressing cells using flow cytometric using anti-AnnexinV and PI staining. Cells were treated with the indicated concentration of DEP for 72 hours. Cells were treated in triplicate and representative FACS profiles are shown on cells stained with APC-AnnexinV and PI. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Supplemental Figure S2 (supporting Figure 2A). Transfection of cells with MIR200 or MIR425 mimics does not regulate UBQLN1 or UBQLN2 levels. H358 and A549 cells were transfected with the indicated miRNA mimic and 72 hours later lysates were prepared and western blotted with the indicated antibodies. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Supplemental Figure S3 (supporting Figure 2E). Correlation between MIR155 expression levels and overall survival in sets of cancer patients from TCGA. See methods for details on analysis. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions

Supplemental Figure S4 (supporting Figure 8F). Raw data for all mice graphed in Figure 8F showing photon emission and actual wet lung weights. Neoplasia 2017 19, 321-332DOI: (10.1016/j.neo.2017.02.001) Copyright © 2017 Terms and Conditions